Clinically shown to help manage blood glucose levels from day 1*1 25 June 2024 Advertisement Good nutrition is essential for diabetes management. Glucerna is a complete and balanced diabetes-specific nutritional supplement scientifically formulated for individuals with diabetes, pre-diabetes or impaired glucose tolerance.2 Glucerna is scientifically designed with 4x Myo-Inositol and a slow-release carbohydrate system3,4,5. It’s a nutritionally complete and balanced low-GI diabetes supplement with 28 vitamins and minerals3 and a heart healthy fat blend developed to help your body work with you. Why Glucerna Stands Out Glucerna is backed by 30 years of scientific research3 and has been clinically shown to help: Manage blood glucose levels from day 1*1 Keep glucose levels within target range up to 90% of the time within 4 weeks^4 What’s in Glucerna? Glucerna contains2: A slow-release low GI carbohydrate blend to help manage blood glucose levels.5,6 Nutritionally complete and balanced diabetes supplement with high quality protein and 28 essential vitamins and minerals. 4 x Myo-inositol to support insulin sensitivity.**7-9 A heart-healthy fat blend.10 Click here to find out more Diabetes Australia does not promote or encourage any single diet or eating plan and there is no one-size-fits-all approach to living well with diabetes. People with diabetes should make their own, informed choices about their diabetes management (including eating plans) in consultation with their diabetes healthcare team. Diabetes Australia does not promote any single product or brand. All Glucerna health claims can be found on the website. Food for Special Medical Purposes. Use under medical supervision. Glucerna is indicated for people with diabetes and/or impaired glucose tolerance as part of a diabetes management plan including diet and exercise. *In the 180 minutes following Glucerna consumption compared to oatmeal in people with type 2 diabetes. The study utlilised a previous Glucerna formulation. ^When used as a breakfast replacement as part of lifestyle modification, blood glucose was within the target glucose range of 3.9 – 10.0mmol/L for an average of 89.5% of the time in people with diabetes. The study utlilised a previous Glucerna formulation. **Compared to Glucerna® S434 per serving. References: 1. Devitt, A., et al. J Diabetes Res Clin Metab. 2012;1(1):2012. 2. Glucerna Powder Product Label. 3 National Library of Medicine, PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=Glucerna&filter=pubt.clinicaltrial&filter=pubt.randomizedcontrolledtrial&filter=pubt.systematicreview (accessed May 2024). 4. Peng, J., et al. Br J Nutr. 2019:121(5):560-566. 5. Glucerna Y495 GI test result. 6. Glucerna Y523 GI test result 7. Bevilacqua A, et al. Int J Endocrinol. 2018:1968450. 8. Dang NT, et al. Biosci Biotechnol Biochem. 2010;74(5):1062–1067. 9. Yamashita Y, et al. J Agric Food Chem. 2013;61(20):4850–4854. 10. West SG, et al. Diabetologica. 2005;48(1):113-122. ANZ.2024.50760.GLU.1 (v1.1)
Blog 27 July 2026 Round up for Diabetes Australia and turn small change into impact Learn how your spare change with Round up goes straight to Diabetes Australia to support programs, research, education, and advocacy. Continue Reading
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
Blog 22 July 2026 Living Out Loud: how Australia spoke up for National Diabetes Week 2026 From 12 to 18 July, Australians living with diabetes, alongside their carers, researchers, health professionals and clinicians, did something powerful. They... Continue Reading